GlobalData on MSN5d
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics
GTCR already owns the second largest medical device coatings manufacturer, Biocoat, and the FTC holds market monopoly ...
JD Supra3d
GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump
In the FTC’s first merger challenge of the new administration, the FTC voted 4-0 last week to challenge the proposed ...
Becker's Hospital Review4d
FTC sues to block merger of device coatings companies
The Federal Trade Commission has filed a lawsuit to block private equity firm GTCR BC Holdings from acquiring Surmodics, a medical technology company, arguing the deal would reduce competition for ...
PE Hub4d
Archimed plans to make BioVendor a European player in diagnostics
Archimed has bought BioVendor, with plans to build and internationalize the Czech diagnostics company. Archimed sees ...
Medical Device Network6d
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics
Image credit: lucasImages via Shutterstock The US Federal Trade Commission (FTC) has sued to block GTCR’s proposed $627m merger-acquisition of critical medical device coatings manufacturer Surmodics ...
ETF Daily News6d
Surmodics (NASDAQ:SRDX) Upgraded at Lake Street Capital
Shares of NASDAQ SRDX opened at $29.37 on Friday. The company’s fifty day moving average is $35.55 and its 200-day moving average is $37.79. The stock has a market cap of $419.87 million, a ...